These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18505395)

  • 1. Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.
    Cornelissen CN
    Future Microbiol; 2008 Jun; 3(3):287-98. PubMed ID: 18505395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
    Baarda BI; Zielke RA; Holm AK; Sikora AE
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Toward a Gonococcal Vaccine: The Way Forward.
    Russell MW; Jerse AE; Gray-Owen SD
    Front Immunol; 2019; 10():2417. PubMed ID: 31681305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
    Semchenko EA; Tan A; Borrow R; Seib KL
    Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological feasibility and importance of a gonorrhea vaccine for global public health.
    Vincent LR; Jerse AE
    Vaccine; 2019 Nov; 37(50):7419-7426. PubMed ID: 29680200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
    Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
    Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
    Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of the Gonococcus: Disease and Pathogenesis.
    Shaughnessy J; Ram S; Rice PA
    Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
    Gulati S; Shaughnessy J; Ram S; Rice PA
    Front Immunol; 2019; 10():321. PubMed ID: 30873172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
    Edwards JL; Jennings MP; Apicella MA; Seib KL
    Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
    Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
    Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic efficacy of a gonococcal vaccine].
    Andreeva ZM; Bednova VN; Shevchenko NM; Malyshev AM; Danilenko TI
    Vestn Dermatol Venerol; 1989; (11):53-5. PubMed ID: 2515676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
    Semchenko EA; Day CJ; Seib KL
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neisseria proteomics for antigen discovery and vaccine development.
    Christodoulides M
    Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
    Rothbard JB; Schoolnik GK
    Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
    [No Abstract]   [Full Text] [Related]  

  • 19. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.
    Gulati S; Agarwal S; Vasudhev S; Rice PA; Ram S
    J Immunol; 2012 Apr; 188(7):3416-25. PubMed ID: 22368277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens.
    Robinson EN; McGee ZA; Buchanan TM; Blake MS; Hitchcock PJ
    Infect Immun; 1987 May; 55(5):1190-7. PubMed ID: 3106215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.